Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study.

BMC Cancer · 2018 · PMC6167904 · PMID 30285733

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP = .06so close (0.05 < p ≤ 0.1)

The odds of developing pneumothorax while being treated with pazopanib did not reach statistical significance on univariate analysis ( P = .06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.